Studies using both mouse cancer models and human subject samples have indicated that increased levels of immature myeloid cells can suppress normal CD8+ cytotoxic T-cell responses and thereby enhance tumor growth [11, 12, 20]. The gene discussed is CD8A; the disease is cancer.